An Integrated Management Pathway for Complex Colorectal Polyps

November 16, 2020 updated by: Unity Health Toronto

An Integrated Strategy for the Expedited Diagnosis, Referral, Assessment and Treatment of Complex Colorectal Polyps

The purpose of this study is to evaluate the impact of implementing an integrated clinical care pathway for the diagnosis, referral, evaluation and treatment of large complex colorectal polyps on clinical outcomes

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Our project will create a system that links community hospitals and ambulatory endoscopy centers throughout the province of Ontario, directly to the expert endoscopists at our tertiary referral center, to facilitate the timely assessment of polyps based on an electronic referral containing endoscopic video recordings or high-resolution images rather than a paper report through a centralized referral pathway. This polyp adjudication will happen in a timely fashion without involving in-person patient consultation, and will streamline the management of these patients to either referral for surgery or booking for endoscopic polyp removal by therapeutic colonoscopy at our center. Specific endoscopy time slots will be reserved for these patients to ensure they have efficient access to their treatment. This system represents a new care model for managing patients with concerning pre-cancerous lesions diagnosed in disparate local hospitals through a centralized process of referral, diagnostic evaluation and treatment at an expert tertiary referral centre.

The primary aim of our study will be to track the outcomes of the new standard-of-care clinical pathway. Clinical objectives of the project include a reduction in wait times for expert assessment after diagnosis of a large or otherwise concerning polyp combined with reduced wait times for therapeutic removal of these polyps, minimizing unnecessary surgery for benign lesions, and facilitating early recommendation for surgery in those patients who truly require surgical resection. Additional objectives include the achievement of excellent rates of clinical success, complication rates similar to those reported in the literature, and high levels of satisfaction from referring doctors at participating centers. A final, major goal is to assess whether this pilot program could serve as a model to be expanded to other academic, tertiary referral centers throughout the province of Ontario.

Our primary research question seeks to compare the diagnostic accuracy of expert polyp adjudication between the different modes of referral (video clip, color photograph, faxed images) against the real-time endoscopic diagnosis during therapeutic colonoscopy and the final pathologic result. The secondary research question is to follow the clinical outcomes of all patients who undergo endoscopic mucosal resection (EMR) of a large or complex colorectal polyp to evaluate the efficacy and safety of this procedure at our expert tertiary referral center.

Study Type

Observational

Enrollment (Anticipated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult patients who were identified to have a large, complex polyp on colonoscopy at a community hospital or ambulatory endoscopy center referred for removal to the therapeutic endoscopy group at St. Michaels Hospital.

Description

Inclusion Criteria:

  • Adult patient 18 years or older
  • Large or complex colorectal polyp found during diagnostic colonoscopy

Exclusion Criteria:

  • Severe medical comorbidities that contraindicate safe endoscopy procedures
  • Inability to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Referred Patients with Large, Complex Colorectal Polyps
Patients referred from outside community care hospitals or ambulatory endoscopy centers to the therapeutic endoscopy group at St. Michaels Hospital via the new integrated management pathway for endoscopic resection of a large or complex colorectal polyp.

The referring doctor will use a standardized template to send the referral along with its associated video or high-resolution photographs.

Referrals will be reviewed in a consensus fashion by at least 2 expert physicians at St. Michael's Hospital (SMH) on a bi-weekly basis. Polyps will be scored using a standardized evaluation form that documents relevant polyp features to assist the determination of whether a lesion is amenable to curative endoscopic resection.

Cases will be triaged as being: (1) a standard polyp suitable for local removal in the community; (2) a complex polyp requiring expert removal at SMH with priority assigned based on the suspected risk of invasive disease; (3) a polyp that is not amenable to endoscopic resection or that is suspicious for cancer will that be recommended for surgical resection.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic accuracy of remote polyp diagnosis (based on video clips, electronic color photographs or paper-based images) compared to real-time endoscopic diagnosis during therapeutic colonoscopy
Time Frame: During Procedure
Determination of diagnostic accuracy (reported as sensitivity and specificity) of video-based vs. real-time endoscopic diagnosis of polyps; diagnostic accuracy of electronic color photo-based vs. real-time endoscopic diagnosis of polyps; diagnostic accuracy of paper-based images vs. real-time endoscopic diagnosis of polyps.
During Procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Wait Times
Time Frame: During Procedure
Wait times (measured in days) from index colonoscopy to polyp adjudication, and from index colonoscopy to therapeutic polyp removal. Comparison will be made to historical wait times for polyps > 2 cm referred to SMH for polyp removal.
During Procedure
Prediction of Polyp Diagnosis
Time Frame: Until availability of histology, generally up to 2 weeks post procedure
Polyp diagnosis based on initial colonoscopy performed at the referring centre, video- or photo-based assessment during polyp triage, and real-time evaluation during colonoscopy by expert endoscopist at SMH, assessed against final pathology from resected polyp specimen.
Until availability of histology, generally up to 2 weeks post procedure
Need for adjunctive removal
Time Frame: During Procedure
Rate of complete snare resection of polyps versus need for the use of combined adjunctive techniques (hot/cold avulsion, argon plasma coagulation, etc.) to achieve removal of polyps.
During Procedure
Prediction of Successful Endoscopic Treatment
Time Frame: Through study completion, up to 1 year
Accuracy (reported as likelihood ratios) of the correct prediction of successful endoscopic treatment based on initial video-based, electronic colour photo-based, or paper image-based assessment during polyp triage compared to real-time evaluation during colonoscopy (prior to commencing attempt at polyp removal), assessed against final endoscopic outcome.
Through study completion, up to 1 year
Procedural complications
Time Frame: Up to 4 weeks
Rate of immediate and delayed complications both intra-procedural and post-procedural up to 4 weeks.
Up to 4 weeks
Residual/Recurrent Polyp
Time Frame: 6 months
Rate and predictors of residual or recurrent polyp at follow-up surveillance colonoscopy.
6 months
Referring Physician Satisfaction
Time Frame: 1 year
Study specific survey consisting of a 5 point likert scale ranging from 1 ("extremely dissatisfied") to 5 ("extremely satisfied"). Assessed at 1 year from initial referral.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christopher Teshima, MD, St. Michaels Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2021

Primary Completion (Anticipated)

January 1, 2023

Study Completion (Anticipated)

January 1, 2024

Study Registration Dates

First Submitted

September 15, 2020

First Submitted That Met QC Criteria

September 29, 2020

First Posted (Actual)

October 6, 2020

Study Record Updates

Last Update Posted (Actual)

November 17, 2020

Last Update Submitted That Met QC Criteria

November 16, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CTO - 1899

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Polyp Colorectal

3
Subscribe